The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit

por Fancellu, A., Sanna, V., Piredda, C., Ariu, L., Piana, G.Q., Deiana, G., Cottu, P., Giuliani, G., Porcu, A.
Publicado 2020

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer

por Porte, B., Carton, M., Lerebours, F., Brain, E., Loirat, D., Haroun, L., Bellesoeur, A., Bach Hamba, S., Kirova, Y., Cottu, P.
Publicado 2020

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

por Laas, E, Mallon, P, Delomenie, M, Gardeux, V, Pierga, J-Y, Cottu, P, Lerebours, F, Stevens, D, Rouzier, R, Reyal, F
Publicado 2015

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

por Baulies, S, Belin, L, Mallon, P, Senechal, C, Pierga, J-Y, Cottu, P, Sablin, M-P, Sastre, X, Asselain, B, Rouzier, R, Reyal, F
Publicado 2015

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation

por Weiswald, L-B, Richon, S, Massonnet, G, Guinebretière, J-M, Vacher, S, Laurendeau, I, Cottu, P, Marangoni, E, Nemati, F, Validire, P, Bellet, D, Bièche, I, Dangles-Marie, V
Publicado 2013

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

por Cottu, P H, Extra, J M, Espie, M, Marolleau, J P, Roquancourt, A de, Makke, J, Miclea, J M, Laurence, V, Mayeur, D, Lerebours, F, Cuvier, C, Marty, M
Publicado 2001

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

por Giacchetti, S, Porcher, R, Lehmann-Che, J, Hamy, A-S, de Roquancourt, A, Cuvier, C, Cottu, P-H, Bertheau, P, Albiter, M, Bouhidel, F, Coussy, F, Extra, J-M, Marty, M, de Thé, H, Espié, M
Publicado 2014

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

por Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Publicado 2014

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado 2010

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

por Grinda, T., Antoine, A., Jacot, W., Blaye, C., Cottu, P.-H., Diéras, V., Dalenc, F., Gonçalves, A., Debled, M., Patsouris, A., Mouret-Reynier, M.-A., Mailliez, A., Clatot, F., Levy, C., Ferrero, J.-M., Desmoulins, I., Uwer, L., Petit, T., Jouannaud, C., Lacroix-Triki, M., Deluche, E., Robain, M., Courtinard, C., Bachelot, T., Brain, E., Pérol, D., Delaloge, S.
Publicado 2021